[SYRE] QoQ Quarter Result on 31-Mar-2017 [#Q1]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
31-Mar-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -13.93%
YoY- -37.39%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 1,482 1,261 1,479 982 1,247 1,149 1,373 5.21%
PBT -6,483 -7,874 -6,632 -6,247 -5,483 -6,238 -5,430 12.50%
Tax 0 0 0 0 0 0 0 -
NP -6,483 -7,874 -6,632 -6,247 -5,483 -6,238 -5,430 12.50%
Tax Rate - - - - - - - -
Total Cost 7,965 9,135 8,111 7,229 6,730 7,387 6,803 11.05%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin -437.45 -624.43 -448.41 -636.15 -439.70 -542.91 -395.48 6.93%
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS 0.00 -12.00 -11.75 -11.68 0.00 -11.70 -11.53 -
EPS Diluted 0.00 -12.00 -11.75 -11.68 0.00 -11.70 -11.53 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.